Genetic pharmacology: progresses in siRNA delivery and therapeutic applications
D Scherman, A Rousseau, P Bigey, V Escriou - Gene therapy, 2017 - nature.com
In the RNA interference process, the catalytic degradation of an endogenous mRNA results
from the Watson-Crick complementary recognition by either a small silencing synthetic …
from the Watson-Crick complementary recognition by either a small silencing synthetic …
Genetic pharmacology: progresses in siRNA delivery and therapeutic applications
D Scherman, A Rousseau, P Bigey, V Escriou - Gene Therapy, 2017 - cnrs.hal.science
In the RNA interference process, the catalytic degradation of an endogenous mRNA results
from the Watson-Crick complementary recognition by either a small silencing synthetic …
from the Watson-Crick complementary recognition by either a small silencing synthetic …
Genetic pharmacology: progresses in siRNA delivery and therapeutic applications.
D Scherman, A Rousseau, P Bigey, V Escriou - Gene Therapy, 2017 - europepmc.org
In the RNA interference process, the catalytic degradation of an endogenous mRNA results
from the Watson-Crick complementary recognition by either a small silencing synthetic …
from the Watson-Crick complementary recognition by either a small silencing synthetic …
Genetic pharmacology: progresses in siRNA delivery and therapeutic applications
D Scherman, A Rousseau, P Bigey, V Escriou - Gene Therapy, 2017 - go.gale.com
In the RNA interference process, the catalytic degradation of an endogenous mRNA results
from the Watson-Crick complementary recognition by either a small silencing synthetic …
from the Watson-Crick complementary recognition by either a small silencing synthetic …
Genetic pharmacology: progresses in siRNA delivery and therapeutic applications
D Scherman, A Rousseau, P Bigey, V Escriou - Gene Therapy, 2017 - hal.science
In the RNA interference process, the catalytic degradation of an endogenous mRNA results
from the Watson-Crick complementary recognition by either a small silencing synthetic …
from the Watson-Crick complementary recognition by either a small silencing synthetic …
Genetic pharmacology: progresses in siRNA delivery and therapeutic applications
D Scherman, A Rousseau, P Bigey… - Gene …, 2017 - pubmed.ncbi.nlm.nih.gov
In the RNA interference process, the catalytic degradation of an endogenous mRNA results
from the Watson-Crick complementary recognition by either a small silencing synthetic …
from the Watson-Crick complementary recognition by either a small silencing synthetic …
[引用][C] Genetic pharmacology: progresses in siRNA delivery and therapeutic applications
D Scherman, A Rousseau, P Bigey, V Escriou - Gene Therapy, 2017 - cir.nii.ac.jp
Genetic pharmacology: progresses in siRNA delivery and therapeutic applications | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …